Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 60-61

  Jordan, S C ^a   Reinsmoen, N ^a   Lai, C H ^a   Cao, K ^a   Kahwaji, J ^a   Peng, A ^a   Villicana, R ^a   Vo, A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; RITUXIMAB; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DECEASED DONOR KIDNEY TRANSPLANTATION; DESENSITIZATION; DRUG EFFICACY; DRUG SAFETY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LOS ANGELES; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84858737133     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.12.028     Document Type: Conference Paper

References (8)

1. F.K. Port, R.A. Wolfe, E.A. Mauger Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients JAMA 270 1993 1339
2. R. Shapiro Reducing antibody levels in patients undergoing transplantation N Engl J Med 359 2008 305
3. N. Shehata, V.A. Palda, R.M. Meyer The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline Transfus Med Rev 24 suppl 1 2010 S7
4. N.L. Reinsmoen, C.H. Lai, A. Vo Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy Transplantation 86 2009 820
5. C.H. Lai, K. Cao, G. Ong Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy Transplantation 92 2011 48
6. A.A. Vo, M. Lukovsky, M. Toyoda Rituximab and intravenous immune globulin for desensitization during renal transplantation N Engl J Med 359 2008 242
7. A.A. Vo, A. Peng, M. Toyoda Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation Transplantation 89 2010 1095
8. J. Kahwaji, A. Sinha, M. Toyoda Infectious complications in kidney transplant recipients receiving rituximab with IVIG for desensitization Clin J Am Soc Nephrol 6 2011 2894